School of Medicine

A School of Medicine study showed that germ-free mice that received two prominent human gut microbes got fatter.

J. William Harbour, M.D., a specialist in diagnosing and treating eye tumors, was named the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences.

School of Medicine researchers will study whether putting a normal-weight person on calorie restriction will change markers of aging,

The new Diabetes Center at the Center for Advanced Medicine will provide a new group-care and patient-education approach.

A stitch in time Using a cow’s heart, Kory Lavine (left) learns to do sutures from fellow student Andrew Harger at clinic orientation for new third-year students June 19. Other students (from left) are Michelle Moniz, Alistair Kent and Jeffrey Lau. Photo credit: Ray Marklin

Photo by Robert BostonJean Audrain in the Department of Internal Medicine receives the Dean’s Distinguished Service Award from Larry J. Shapiro, M.D., executive vice chancellor and dean of the School of Medicine.

The opening is part of a long-term plan to make Euclid Avenue a more pedestrian-friendly zone.

WellingThe Washington University Diabetes Center at Barnes-Jewish Hospital focuses on providing patients with the latest technology, treatments and clinical research. Some patients at the center are receiving a new diabetes drug that may give a welcome side effect — weight loss. Research lab supervisor Cris Welling began taking Byetta about 10 months ago and has lost 40 pounds.

Like the fictional wizard Harry Potter, some cancerous tumors seem capable of wrapping themselves in an invisibility cloak. Researchers at the School of Medicine have found that pancreatic tumors hide from the body’s immune surveillance by surrounding themselves with cells that make it hard for the immune system to detect them.

TobinPatients managing diabetes can now get full diagnostics, treatment and education in one place — the Washington University Diabetes Center at Barnes-Jewish Hospital. The center will provide a new group-care and patient-education approach for patients with type 1 or type 2 diabetes, says Garry Tobin, medical director of the center.